CSI Market
Sign In | Register

Precision Biosciences Inc (DTIL) Annual Balance Sheets

Annual · GAAP · USD millions
Access DTIL quarterly Balance Sheets →
The data below summarizes Precision Biosciences Inc's balance sheet position from Dec 31 2021 to Dec 31 2025, enabling a period-by-period comparison of financial strength.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Annual Report, GAAP in USD millions
ITEM 		(Dec 31 2025)
(Dec 31 2024) (Dec 31 2023) (Dec 31 2022) (Dec 31 2021)
Assets
Cash & cash equivalent110.82
Marketable Securities, Current SH4.76
Cash & Short-term Investments114.00
Accounts receivable0.00
Financing Receivable, Net, Total NO0.00
Notes, Loans and Financing Receivable, Net, Current AC0.00
Other Current Assets0.05
Prepaid Expense, Current AS3.11
Total Current Assets118.74
Equipment/Property/Plant Net1.43
Intangible Assets1.17
Long-term investments26.33
Other Assets, Noncurrent33.09
Assets Held For Sale Not Part Of Disposal Group Current-
Operating Lease Right Of Use Asset5.81
Total Assets154.42
Liabilities
Accounts Payable, Current AC0.30
Employee-related Liabilities, Current AC4.75
Loans Payable, Current NO0.00
Other Liabilities, Current3.87
Disposal Group, Including Discontinued Operation, Liabilities, Current LI0.00
Total Current Liabilities8.91
Long-term debt22.40
Total Long-term Debt22.40
Disposal Group, Including Discontinued Operation, Liabilities, Noncurrent LI0.00
Other liabilities, Noncurrent30.85
Operating Lease Liability Current1.51
Contract With Customer Liability Current-
Contract With Customer Liability Noncurrent-
Operating Lease Liability Noncurrent4.90
Total Liabilities62.17
Stockholders' Equity
Common Stock Value0.00
Treasury Stock Value-0.95
Additional Paid In Capital Common Stock621.39
Retained Earnings / Accumulated Deficit-528.19
Other Equity0.00
Common Stockholder's Equity92.25
Total Stockholder's Equity92.25
Liabilities & Stockholder's Equity154.42
4 historic quarters locked

Sign in to unlock the full Precision Biosciences Inc balance sheet history.

Sign In Create Free Account

About Precision Biosciences Inc Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-K filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001628280-26-017019

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.